Top ways to close the evidence gap before year end: taXonomy Pathways
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
At HealthVerity, community is at the heart of who we are. Each year, our team members come together...
AI agents are quickly becoming part of the clinical conversation. Since the release of large...
Digital health innovators and pharma leaders are under increasing pressure to show that new models...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
(Part 2) In Part 1 we explored how HealthVerity Marketplace delivers high-quality,...
Few areas of medicine have captured public interest over the past two years quite like...
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS) and can lead to significant disability over time. It remains the most common inflammatory neurological condition worldwide and in the United States alo...